Nexium and Mean cell volume increased - a phase IV clinical study of FDA data

Summary:

Mean cell volume increased is reported as a side effect among people who take Nexium (esomeprazole magnesium), especially for people who are female, 60+ old, also take Zoloft, and have Diabetes.

The phase IV clinical study analyzes which people have Mean cell volume increased when taking Nexium. It is created by eHealthMe based on reports of 240,870 people who have side effects when taking Nexium from the FDA, and is updated regularly.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,677 Nexium users. Check the latest studies of Nexium.

What is Mean cell volume increased?

Mean cell volume increased (more than normal average red blood cell volume) is found to be associated with 455 drugs and 495 conditions by eHealthMe. Check the latest studies of Mean cell volume increased.

On Jul, 13, 2026

240,870 people reported to have side effects when taking Nexium.
Among them, 43 people (0.02%) have Mean cell volume increased.

Could Nexium cause Mean cell volume increased?

Among these 43 people:

What is the gender of people who have Mean cell volume increased when taking Nexium? *

female: 64.1 %
male: 35.9 %

What is the age of people who have Mean cell volume increased when taking Nexium? *

What are other drugs people take besides Nexium? *

What are other side effects people have besides Mean cell volume increased? *

Fatigue (feeling of tiredness): 23 people, 53.49%
Haemoglobin Decreased: 21 people, 48.84%
Red Blood Cell Count Decreased: 21 people, 48.84%
Thrombocytopenia (decrease of platelets in blood): 19 people, 44.19%
White Blood Cell Count Decreased: 17 people, 39.53%
Nausea (feeling of having an urge to vomit): 16 people, 37.21%
Pain: 16 people, 37.21%
Diarrhea: 14 people, 32.56%
Platelet Count Increased: 13 people, 30.23%
Anaemia (lack of blood): 13 people, 30.23%

What are the existing conditions these people have? *

Diabetes: 7 people, 16.28%
Osteoporosis (bones weak and more likely to break): 6 people, 13.95%
Multiple Myeloma (cancer of the plasma cells): 5 people, 11.63%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 5 people, 11.63%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 11.63%
Depression: 5 people, 11.63%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 4 people, 9.30%
Essential Hypertension (primary hypertension): 4 people, 9.30%
High Blood Pressure: 4 people, 9.30%
Ovarian Cancer (cancer of ovary): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Nexium and have Mean cell volume increased?

- Check whether Mean cell volume increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nexium:

Nexium (245,677 reports)

Browse all side effects of Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mean cell volume increased:

Mean cell volume increased (455 drugs)

Browse all the conditions that are associated with Mean cell volume increased:

Mean cell volume increased (495 conditions)

Related publications that referenced our studies

Dr. Anthony Wong, "Esomeprazole and gynaecomastia in obese adults", WHO pharmaceuticals newsletter: 2019, No. 2, 2019 Jan .
Dr. Anthony Wong, "Esomeprazole and gynaecomastia in obese adults", WHO pharmaceuticals newsletter: 2019, No. 2, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on esomeprazole magnesium (the active ingredients of Nexium) and Nexium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.